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Abstract 
BACKGROUND – The bacterium Escherichia coli is a commonly used host for the 
production of recombinant protein biopharmaceutical products. One class of such molecules 
is antibody fragments, typified by the Crohn’s disease and rheumatoid arthritis therapy 
Certolizumab pegol (Cimzia®). Antibody fragments generated in E. coli are often directed to 
the periplasm, so that disulphide bonding can occur and release can be simplified. However, 
many recombinant protein products are prone to misfolding and mislocalisation. Here, we 
optimised the production of a Fab fragment, D1.3, and its release from the periplasm of E. 
coli using osmotic shock.  
RESULTS – By minimising stress imposed on the bacterial hosts and monitoring Fab, total 
protein and DNA concentrations of fractions isolated following osmotic release, we 
successfully targeted the majority of recombinant Fab to the periplasm and were able to 
rapidly define optimal harvest points. Coupled optimisation of fermentation and release 
increased the Fab concentration of the periplasmic extract by more than 20-fold.    
CONCLUSION – Simultaneous optimisation of fermentation and periplasmic release allowed 
rapid definition of operational space and generation recombinant protein in a form 
compatible with downstream processing steps. This methodology could be used for 
optimisation of the production of a range of periplasmically-targeted recombinant proteins. 
 
Keywords: Recombinant protein production; Fab fragment; Periplasmic release; High Cell 
Density Culture 
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INTRODUCTION 
Around 30% of protein biopharmaceuticals are generated in bacterial hosts.1,2 Of these, 
antibody fragments are a growing class of protein biopharmaceuticals, comprising the 
antigen-binding regions of full-length human antibodies.3 The Fab fragment comprises the 
light chain variable and constant domains (VL and CL) and the variable and constant-1 
domains of the heavy chain (VH and CH1) of the human immunoglobulin, disulphide bonded 
together. Although more rapidly cleared from circulation than full-length antibodies, antibody 
fragments allow greater tissue penetration and can be generated in bacterial hosts.4 The 
Crohn’s disease and rheumatoid arthritis therapy Certolizumab pegol (Cimzia®, UCB) is 
based on a Fab fragment expressed in E. coli.2   
Such recombinant proteins provide a challenge for E. coli, as they require disulphide 
bonding. Two possible approaches are used to permit this: use of thioredoxin mutant stains 
with an oxidising cytoplasm (as opposed to its natural reducing state)5; or (more commonly) 
translocation of the recombinant polypeptide chains to the naturally-oxidising periplasm, 
where the E. coli disulphide bond chaperones (Dsc proteins) are located.6 Generation of an 
oxidising cytoplasm in E. coli can lead to metabolic problems and poor growth, so the latter 
route is frequently favoured. Theoretically, accumulation of Fab fragments in the periplasm 
also simplifies downstream processing. Complete cell lysis by mechanical (e.g. high 
pressure homogenisation) or non-mechanical means7, required for release of cytoplasmic 
proteins, is not needed; rather, the outer membrane can be stripped away using osmotic 
shock8 or mild heat treatments.9,10   
The resultant periplasmic extract is thereby already enriched for the recombinant protein of 
interest, the periplasm containing only around 4 % to 8 % of the natural E. coli cellular 
proteins, making purification simpler.11 The periplasmic extract is also of lower volume than a 
whole cell lysate. In addition, periplasmic protease activity is far lower than that in the 
cytoplasm, reducing proteolysis of the recombinant protein product. In order for periplasmic 
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release to succeed, bacterial viability and physical integrity must be maintained upon 
harvest. Metabolic stress in bacteria generating recombinant proteins such as 
periplasmically-targeted Fab fragments can cause cell lysis during fermentation or fragility 
leading to lysis during cell harvesting in industrial centrifuges or subsequent processing 
steps.12,13,14 This eliminates the advantages of periplasmic expression as cytoplasmic 
proteins, membrane components and DNA are all released, complicating subsequent 
purification of the target recombinant protein.  
Recent work has focused on minimisation of stress encountered by bacteria generating 
cytoplasmic recombinant proteins by decreasing growth temperature and inducer 
concentration.1,15 This stress-minimising approach results in slower recombinant protein 
synthesis, but permits correct folding and processing of the resultant recombinant protein. 
The result is an increase in not only the yield but also the solubility of recombinant protein. 
Additionally stress minimisation dramatically limits plasmid loss, increases cell viability and 
improves process robustness. In this study, stress minimisation strategies were used to: (i) 
increase the yield of a Fab fragment in the periplasm of E. coli; and (ii) optimise its release 
using osmotic shock. Through manipulation of growth temperature, inducer concentration 
and the point of induction, the Fab fragment could be directed to accumulate in the 
periplasm, significantly simplifying purification. This approach, simultaneously assessing the 
effect of stress minimisation on both fermentation and product release, was able to rapidly 
assess operational space for both upstream and downstream processes, effectively 
optimising the whole process. We anticipate that this optimisation method could prove an 
effective strategy to employ during development of new recombinant protein production and 
release processes. 
EXPERIMENTAL 
E. coli cultivation 
The tetracycline resistant E. coli CLD048 used in this study was provided by FUJIFILM 
Diosynth Biotechnologies (formerly Avecia Biologics) Billingham, UK and expresses the D1.3 
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anti-Hen Egg White Lysozyme Fab, directing the heavy and light chains into the periplasm.16 
Fermentation inocula were prepared by inoculating 100 mL of Luria Bertani (LB) broth (0.5% 
w/v yeast extract, 1% w/v tryptone and 1% w/v NaCl) in a conical flask containing 15 mg·L-1 
tetracycline with a fresh single colony of E. coli CLD048 and shaking at 37°C (fermentation 1 
only) or 30 °C and 200 rpm for 13 h. Fermentation was conducted in a 5 L Electrolab FerMac 
310/60 fermenter (Tewkesbury, UK). The vessel was filled with 3 L of a medium comprising 
14 g·L-1 (NH4)2SO4, 35 g·L-1 glycerol, 20 g·L-1 Yeast extract , 2 g·L-1 KH2PO4, 16.5 g·L-1 
K2HPO4, 7.5 g·L-1 citric acid and 1.5 mL·L-1 H3PO4)17, autoclaved and allowed to cool before 
addition of 30 mL of 1 M MgSO4.7H2O solution, 6 mL of 1 M CaCl2.2H2O solution, 0.6 mL of 
Antifoam AF204, 3 mL of 15 mg·mL-1 Tetracycline and 34 mL of trace metal solution (3.36 
g·L-1 FeSO4.7H2O, 0.84 g·L-1 ZnSO4.7H2O, 0.51 g·L-1 MnSO4.H2O, 0.25 g·L-1 Na2MoO4.2H2O, 
0.12 g·L-1 CuSO4.5H2O, 0.36 g·L-1 H3BO3 and 48 mL·L-1 concentrated H3PO4, in H2O, filter 
sterilised). The pH of the medium was adjusted to 7.0 using NH4OH. Full details of materials 
used are listed in the supplementary experimental section (supporting materials).  
 
At start-up the agitation and air-flow rates were set at 200 RPM and 1.0 VVM respectively 
and the pH was adjusted to 7.0 using 10% (v/v) NH4OH. Thereafter the agitation speed was 
progressively increased (up to maximum value of 1000 rpm) to sustain the dissolved oxygen 
tension (DOT) at the set point of 30%. Once the carbon source had been depleted, indicated 
by an increased DOT feeding (with 714 g·L-1 glycerol and 30 mL·L-1 1 M MgSO4) was 
started. The feed profiles employed were constant in the case of fermentations 1 & 2 (at 90 
mL·h-1) and exponential for the remaining fermentations (3-7) according to the following 
equation:18 
 
Where: F is the feed rate into the bioreactor (L·h-1); X0 is the biomass at start of feed (g dry 
cell weight); μ is the specific growth rate (set to 0.3 h-1); t is the time (h); S is the glycerol 
concentration (714 g·L-1) in the feed; Yxs is the cell yield on glycerol (616.7 mg biomass g 
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glycerol-1)19; and m is the maintenance coefficient for glycerol (3.683 mg glycerol g cell-1 h-
1).19  
 
Osmotic shock separation of periplasmic and cytoplasmic fractions 
One millilitre samples of fermentation broth were centrifuged in a microcentrifuge (15800 gav, 
120 s). The supernatants (culture broth fractions) were carefully removed, and the cell 
pellets were resuspended in ‘osmotic shock solution 1’ (20 mM Tris-HCl buffer, pH 8 
supplemented with 2.5 mM EDTA and 20% w/v sucrose). After incubation on ice for 600 s, 
the treated cells were recovered by recentrifugation (15800 gav, 120 s), and the supernatants 
(OS1 fractions, containing periplasmic proteins) were pipetted off and retained. 
Subsequently the pelleted spheroplasts were re-suspended in 1 mL of ‘osmotic shock 
solution 2’ (20 mM Tris-HCl pH 8 2.5 mM EDTA) and incubated on ice for a further 600 s, 
before finally centrifuging the samples (as above), removing and retaining the supernatants 
(OS2 fraction, containing cytoplasmic proteins). All of the generated fractions were stored at 
-20 °C prior to be subjecting to further analysis by (SDS-PAGE, protein or DNA assay). 
 
Fractionation of soluble and insoluble proteins from cell pellets 
‘Bugbuster’ reagent (Merck) was employed to separate soluble and insoluble proteins from 
E. coli pellets. Portions (1 mL) of fermentation broth were subjected to centrifugation (15800 
gav, 600 s) in a microfuge. The supernatants were removed, and the pellets were 
resuspended in a calculated volume (i.e. ‘67 × culture OD600’ μL) of ‘Bugbuster’ reagent. 
After incubating for 900 s at room temperature, the ‘Bugbuster/cell’ cocktails were 
centrifuged (15800 gav, 1200 s) in a refrigerated microcentrifuge (4 °C), and the supernatants 
(containing soluble proteins) and pellets (containing insoluble proteins) were separated from 
one another. The supernatants were immediately mixed with equal volumes of Laemmli 
Sample Buffer (65.8 mM Tris-HCl, pH 6.8, 2.1% w/v SDS, 26.3% w/v glycerol, 0.01% w/v 
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bromophenol blue and 5% v/v β-mercaptoethanol)20, whereas the pellets were washed with 
phosphate buffered saline, resuspended in ‘67 × culture OD600’ μL of Laemmli buffer and 
boiled for 600 s.   
 
SDS polyacrylamide gel electrophoresis (SDS-PAGE)  
The protein compositions of soluble (10 μL) and insoluble (5 μL) protein samples prepared 
above were analysed by reducing SDS-PAGE20 in a Mini-Protean® Tetracell electrophoresis 
system (Bio-Rad Laboratories, Hercules, CA, USA). Prior to electrophoresis, all samples 
were diluted 1:1 with the Laemmli Sample Buffer,20 boiled at 110°C for 600 s, and then 
centrifuged (7000 gav, 15 s), before loading into the wells of the of a precast 15% (w/v) 
polyacrylamide gel (Bio-Rad Laboratories, Hercules, CA, USA). SeeBlue Plus2 Pre-Stained 
Standard (Invitrogen) was used for estimation of molecular weight of protein bands on the 
gel. Following electrophoresis, gels were rinsed three times with 100 mL of water and then 
stained with SimplyBlue Safe Stain (Invitrogen) for 1 h at room temperature with gentle 
shaking. The stain was discarded and the gel was subsequently washed twice with 100 mL 
of distilled water for 1 h with gentle shaking.  
 
Western Blotting 
Proteins were separated by SDS-PAGE and the gel soaked in protein transfer buffer (3.03 
g·L-1 Trizma-base, 14.4 g·L-1 glycine and 200 mL·L-1 methanol) for 30 minutes. Hybond-P 
PVDF membrane and six layers of thick filter paper (Whatman GB005) were cut to the 
dimensions of the gel, soaked in methanol for 10 seconds, washed in distilled water for 5 
minutes, and equilibrated in protein transfer buffer for 30 minutes. The electroblotting 
cassette was assembled according to the manufacturer’s instructions with three layers of 
filter paper on each side of the gel and membrane (Mini Trans-Blot electrophoretic Transfer 
Cell, Bio-Rad, CA, USA). The transfer was carried out initially for 1 h at 100 V with transfer 
buffer at 4 °C, and was then perpetuated at 30 V overnight at 4 °C. Following transfer, the 
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membrane was removed from the blotting cassette and rinsed briefly in PBS. The membrane 
was blocked (3% (w/v) BSA in PBS, 1 hour), rinsed three time (0.1 % (v/v) Tween 20 in PBS, 
5 minutes each) and incubated with antibody (anti-human IgG (Fab specific) peroxidase 
conjugated (Sigma) diluted in PBS 10 000-fold) for 1 h. The blot was washed three times 
(0.1 % (v/v) Tween 20 in PBS, 5 minutes each) before incubation with 15 mL of TMB 
membrane peroxidise substrate system (3-C) solution (KPL, Gaithersburg, MD, USA) until 
desired band intensity was achieved. The reaction was stopped by washing in distilled water. 
Blots were scanned (Canon Canoscan 9000F) and ImageJ21 was used to determine the 
relative quantity of soluble and insoluble D 1.3 protein. 
 
Sandwich ELISA  
Each well of a 96-well microtiter plate was coated overnight at 4 °C with 100 μL of 0.1 % 
(w/v) hen egg white lysozyme (Sigma) in coating buffer (1.59 g·L-1 Na2CO3 and 2.93 g·L-1 
NaHCO3). Nonspecific binding was blocked by incubation for 1 hour at 37 °C with 200 μL of 
10 g·L-1 BSA (Sigma) in PBS. Wells were washed three times with 300 μL of wash buffer 
(0.1 % (v/v) Tween 20 in PBS) per well and tap dried. 100 μL of standards (Purified Fab 
D1.3, supplied by Reza Jalalirad) or samples were loaded into each well and incubated at 37 
°C for 1 h with shaking. The plate was washed again with wash buffer three times and tap 
dried. Each well was then loaded with 100 μL of antibody (anti-human IgG (Fab specific) - 
peroxidase conjugated antibody produced in goat (Sigma), diluted 10 000-fold in the block 
buffer) and incubated at 37 °C for 1 h. The plate was washed again three times tap dried, 
before 100 μL of peroxidase substrate (TMB microwell peroxidase substrate (2-C), KPL, 
Gaithersburg, MD, USA) was added to each well. The reaction was stopped after 10 minutes 
by adding 100 μL of 1 M H3PO4 to each well, and the plate was read at 450 nm using a 
microplate reader (Promega Glomax-Multi detection system, Turner BioSystems Inc., 
Sunnyvale, CA, USA). 
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DNA and protein assays 
DNA concentrations in samples were determined using a diphenylamine (DPA) based 
colorimetric assay22 adapted for use in a microwell plate format. Standards (1 mg·mL-1 
sonicated calf thymus DNA (3-20 kb in size) in 10 mM Tris-HCl, 1 mM EDTA, pH 8) and 
samples were dispensed into the wells of a 96 well plate and each well made up to 175 μL 
with 10 mM Tris-HCl, 1 mM EDTA, pH 8. To each well was added 5 µL of 2 mg·mL-1 BSA in 
water and 200 µL of 0.4 M perchloric acid (PCA) and the plate incubated at 4 ˚C for 0.5 h. 
Plates were centrifuged (15800 gav, 1200 s), the supernatant discarded, 250 µL of 1 M PCA 
added to each pellet, vortexed, transferred to a microfuge tube and incubated at 70°C for 0.5 
h. Once cooled to room temperature, 500 µL of freshly prepared chromogenic reagent (1.5 g 
diphenylamine, 100 mL of glacial acetic acid and 1.5 mL of concentrated H2SO4, with the 
addition of 0.5 mL ethanol mixed with 25 mL of water immediately prior to use) was added to 
each tube. After overnight incubation and subsequent centrifugation (15 800 gav, 600 s) the 
absorbance of the supernatant was measured in a spectrophotometer at a wavelength of 
600 nm. The amount of total protein present in the samples was measured using a 
bicinchoninic acid assay (BCA assay kit, Thermo Scientific, Rockford, IL, USA) employing 
bovine serum albumin (BSA) as a standard. 
 
RESULTS AND DISCUSSION 
 
Fed-batch fermentation using conventional approaches  
In order assess the impact of altering fermentation conditions on product capture from the E. 
coli periplasm, an integrated approach was used to analyse Fab production. Following 
collection of samples, bacteria were harvested by centrifugation; the supernatant comprised 
the culture broth fraction. Bacteria were subjected to osmotic treatment, generating two 
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further fractions:  OS1, comprising the periplasm; and OS2, containing the cytoplasmic 
proteins. Concentrations of Fab D1.3 product in each fraction were measured by ELISA.  
The initial fed-batch fermentation conditions were taken from Hodgson et al.16 The 
temperature was set at 37 °C and glycerol was fed when the carbon source in the initial 
batch medium was depleted (8 h after inoculation, determined by a decrease in OD600 
reading). Fab production was induced after 10 h growth at an OD600 of around 61 with 100 
μM IPTG (Fig. 1a). 
Upon induction, growth slowed and reached a peak biomass (OD600 = 70) 6 h after induction, 
followed by a decrease in biomass concentration thought to be due to cell lysis. ELISA data 
(Fig. 1b) revealed that very low quantities of Fab D1.3 were generated during the 
fermentation, up a maximum of around 1.4 mg·L-1. Although the majority of this Fab was 
present in the periplasmic (OS1) fraction, the yield was too low to be commercially viable (a 
maximum of 1 mg·L-1), especially when compared to other expression data in the literature 
(for example, Humphreys & Bowering10). In addition, the quantity of Fab D1.3 in the culture 
broth rapidly increased towards the end of the fermentation, signifying cell lysis.  
In order to improve the yield of Fab D1.3, the growth temperature was decreased to 30 °C 
(Fig. 1c). Other parameters were kept the same as fermentation 1. Growth stopped around 4 
h following induction of Fab production at a maximum OD600 of 63, and although the total 
Fab yield was far higher (peaking at >31 mg·L-1), at 4 h post-induction onwards most of the 
Fab was present in the culture broth fraction, with only a small quantity in the periplasmic 
fraction (Fig. 1d).  
Since E. coli does not naturally secrete recombinant proteins, this is due to release of 
periplasmic Fab by outer membrane damage. This is problematic for industrial processes 
since periplasmic release requires bacteria to be physically intact to permit selective release 
of periplasmically-targeted recombinant proteins and prevent release of cytoplasmic proteins 
during centrifugal cell harvesting or osmotic release procedures.12,14 If bacteria are physically 
weakened, for example by RPP-induced stress, then far more protein is released, 
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complicating DSP; the advantages of periplasmic targeting and release are minimal as 
compared to cytoplasmic expression, lysis and purification from whole cell lysate. In addition, 
cell lysis dramatically increases the conductivity of the culture broth, making 
chromatographic separation difficult without extensive feedstock conditioning steps. 
Therefore the Fab D1.3 production process was optimised to maximise Fab yield and purity 
in the periplasmic (OS1) fraction. This provides a useful indication of both Fab productivity 
and the physical state of the bacteria, in particular the ability of the outer membrane to 
contain periplasmic proteins. Ideally, a large quantity of Fab should accumulate in the 
periplasm, contained within a robust outer membrane, which can be readily released by 
osmotic shock. In addition, fermentations were optimised to prolong the growth of cultures 
following induction. 
 
Stress minimisation 
Stress-minimisation15,23 was applied to Fab D1.3 production in order to improve protein yield 
and direct Fab to the periplasm. As well as previously observed benefits of this approach 
(higher yield and better folding of cytoplasmically-targetted recombinant protein), we wanted 
to investigate whether stress minimisation also allowed correct targeting into the periplasm 
and increased physical integrity of bacteria.   
Initial scoping studies in shake flasks at 100 mL scale generated promising results (data not 
shown), so the approach was implemented in bioreactor cultures. The first stress-minimising 
bioreactor growth employed three principles of stress-minimised RPP15,23: Growth at 25 °C, 
which decreases both the rate of cell division and thus nutrient requirements for biomass 
production and protein synthesis rates; induction with a low quantity of the inducer IPTG (20 
μM), which decreases the rate of Fab production; and early induction (at an OD600 of around 
1), permitting concurrent Fab production and biomass generation. In addition to ELISA 
quantification of Fab D1.3 in the osmotic shock fractions, total protein concentrations were 
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measured along with the concentration of DNA in the culture broth as an indicator of cell 
lysis. 
Unlike previous fermentations (Fig. 1), bacteria continued growing for a significant time 
following induction (reaching an OD600 of 47 after 31 h; Fig. 2a), signifying that growth and 
RPP were balanced. The lower growth temperature and thus growth rate also ensured that 
dissolved oxygen was maintained throughout. Total Fab D1.3 concentration increased 
steadily over time after induction, reaching around 11 mg·L-1 after 27.5 h post-induction (Fig. 
2b). As before, a small quantity of Fab (<1 mg·L-1) was detected in the cytoplasmic fraction, 
corresponding to newly-synthesised Fab protein before transport to the periplasm. 
Periplasmic Fab concentration steadily increased, although the culture broth Fab 
concentration also increased, indicating cell lysis; this was confirmed by increased DNA 
concentrations present in the culture broth (Fig. 2c). Total protein concentration of the 
periplasmic fraction was between 1-1.6 g·L-1, resulting in a maximum Fab purity of 0.8 % at 
22.5 h post-induction. 
This fermentation protocol was repeated with induction at an OD600 of around 20 (Fig. 2d); 
this resulted in a higher final OD600 of >80. However, total Fab concentrations were not 
significantly higher than in cultures induced at a lower OD600 (Fig. 2e), and far more of the 
Fab was contained within the cytoplasmic fraction, resulting in a lower periplasmic Fab yield. 
The total protein concentration of the periplasmic fraction was also lower; this might reflect a 
difference in the stability of the cell envelope during growth in conditions where induction 
proceeds at a higher biomass. This is also reflected by the lower culture broth DNA 
concentration observed in this fermentation (Fig. 2f). 
In order to increase the yield of periplasmic Fab, the concentration of inducer IPTG was 
increased to 100 μM, added at an OD600 of around 20 (Fig. 3). This increase in IPTG 
concentration generated far more Fab; total titres reached above 41 mg·L-1. The periplasmic 
Fab concentration peaked at around 12 mg·L-1 at 11 h post-induction (28 h after inoculation). 
Although an improvement over previous fermentations, the relatively high protein 
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concentration of the periplasmic extract meant that Fab purity in the periplasmic extract was 
still only 0.6 %. After 11 h post-induction, most of the Fab was located in the culture broth 
(up to a maximum of up to 35 mg·L-1), indicating extensive cell lysis; this was confirmed by 
high culture broth DNA concentrations (>300 mg·L-1) that increased over the course of the 
fermentation.  
The increase of inducer concentration to 100 μM increased stress during the fermentation; to 
balance this increased stress and resultant cell lysis, while maintaining a higher Fab titre, the 
growth temperature was further decreased following induction at an OD600 of around 20 to 20 
°C (Fig 4a). At the end of the fermentation, total Fab accumulation was again around 40 
mg·L-1; however, nearly half of the Fab was located in the periplasmic fraction (Fig. 4b). The 
optimal harvest point for this fermentation was found to be 18.5 h post-induction (36.5 h after 
inoculation); after this point, the culture broth Fab and DNA concentration both increased, 
indicating cell lysis (Fig. 4c). At 18 h post-induction, the Fab concentration of the periplasmic 
extract was 15.8 mg·L-1, while total protein concentration was 0.85 g·L-1, resulting in a purity 
of 1.9 % (Table 1). 
Finally, the IPTG concentration was increased to 0.2 mM to attempt to increase the yield of 
Fab D1.3 without detrimentally impacting the harvest window or cell integrity (Fig. 4d). Under 
these conditions, Fab accumulated in the periplasmic fraction more quickly than when 100 
μM IPTG was used to induce RPP; the harvest point can be defined as 8 h post-induction 
(26 h after inoculation), when 20 mg·L-1 Fab D1.3 had accumulated in the periplasmic 
fraction, representing the majority (86 %) of all generated Fab (Fig. 4e). The purity of the 
periplasmic fraction at this point was 1.7%, comparable to the previous fermentation. Thus, 
increasing IPTG concentration effectively brought the time of harvest forward by 10 h when 
compared to use of 0.1 mM IPTG (Fig. 4a), and boosted Fab titre in the periplasmic fraction 
by 27 %. At timepoints later than 8 h post-induction, increases in the Fab and DNA 
concentration in the culture broth indicated cell lysis (Fig. 4f).  
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As well as ELISA analysis of Fab yields in each subcellular fraction, SDS-PAGE and 
Western blotting were used to determine the quantity of Fab D1.3 present in soluble and 
insoluble (inclusion body) forms. Bacterial pellets harvested at the end of each fermentation 
were fractionated into soluble and insoluble fractions using the Bugbuster® reagent (Table 
1). The stress minimisation methods clearly improved the solubility of Fab D1.3 whereas 
high-stress fermentation conditions drove Fab into the insoluble fraction (Fermentations 3-7 
compared to 1 and 2).  
This logical method to fermentation optimisation using stress-minimisation is an alternative 
approach to Design of Experiments (DoE) approaches, where computational tools are used 
to define a limited number of experiments that rapidly explore multi-parameter experimental 
space. Future work will compare DoE and logic-based approaches to the optimisation of 
fermentation and periplasmic release of recombinant proteins. 
 
CONCLUSIONS 
We have demonstrated that stress minimisation by decreasing culture temperature and 
inducer concentration can be used to improve not only recombinant protein yields and 
folding15,23 but also correct subcellular targeting and overall cell integrity for subsequent cell 
harvest and protein release steps.12,13,14 Careful balancing of increases in inducer 
concentration and decreases in growth and induction temperature allowed optimisation of 
Fab D1.3 yield. We have also demonstrated the benefits of optimising periplasmically-
targeted recombinant protein production using a coupled fermentation – release approach; 
optimisation of the fermentation stage only would not generate insights into the 
processability of the biomass generated and its applicability for subsequent periplasmic 
release and purification of the resultant recombinant proteins. Future studies will expand 
upon these findings by using a DoE approach to further optimise coupled fermentation and 
release of recombinant proteins. 
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Figure 1. Fermentations 1 and 2 using conventional parameters. For fermentation 1, the 
conditions were a cultivation temperature of 37°C and induction with 0.1 mM IPTG at an 
OD600 of ~40. (a) Online fermentation parameters (Dissolved oxygen%, Temperature and 
pH). The arrow indicates the point of induction. (b) Optical density at 600 nm and 
concentration of Fab D1.3 measured by ELISA in each fraction. For fermentation 2, the 
conditions were a cultivation temperature of 30°C and induction at an OD600 of ~ 40 with 0.1 
mM IPTG. (c) Online fermentation parameters (Dissolved oxygen%, Temperature and pH). 
The arrow indicates the point of induction. (d) Optical density at 600 nm and concentration of 
Fab D1.3 measured by ELISA in each fraction. OS1, periplasmic extract; OS2, cytoplasmic  
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extract; CB, culture broth. 
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Figure 2. Fermentations 3 and 4 using stress minimisation. For fermentation 3, the 
temperature was 25°C and RPP was induced with 20 μM IPTG at an OD600 ~1. (a) Online 
fermentation parameters (Dissolved oxygen%, Temperature and pH). The arrow indicates 
the point of induction. (b) Optical density at 600 nm and concentration of Fab D1.3 measured 
by ELISA in each fraction. (c) Concentration of total protein in each fraction measured by 
BCA assay and concentration of DNA in culture broth measured by DPA assay. For 
fermentation 4, conditions were as fermentation 3 except that induction with 20 μM IPTG 
occurred at an OD600 ~20. (d) Online fermentation parameters (Dissolved oxygen %, 
Temperature and pH). The arrow indicates the point of induction. (e) Optical density at 600 
nm and concentration of Fab D1.3 measured by ELISA in each fraction. (f) Concentration of 
total protein in each fraction measured by BCA assay and concentration of DNA in culture 
broth measured by DPA assay. OS1, periplasmic extract; OS2, cytoplasmic extract; CB, 
culture broth. 
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Figure 3. Fermentation 5 using stress minimisation but a higher IPTG concentration. 
The temperature was 25 °C and RPP was induced with 0.1 mM IPTG at an OD600 ~20. (a) 
Online fermentation parameters (Dissolved oxygen%, Temperature and pH). The arrow 
indicates the point of induction. (b) Optical density at 600 nm and concentration of Fab D1.3 
measured by ELISA in each fraction. (c) Concentration of total protein in each fraction 
measured by BCA assay and concentration of DNA in culture broth measured by DPA assay. 
OS1, periplasmic extract; OS2, cytoplasmic extract; CB, culture broth.  
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Figure 4. Fermentations 6 and 7 using stress minimisation and an additional 
temperature decrease. For fermentation 6, the temperature was 25 °C before induction. 
RPP was induced with 0.1 mM IPTG at an OD600 ~20, after which the growth temperature 
was decreased to 20 °C. (a) Online fermentation parameters (Dissolved oxygen%, 
Temperature and pH). The arrow indicates the point of induction. (b) Optical density at 600 
nm and concentration of Fab D1.3 measured by ELISA in each fraction. (c) Concentration of 
total protein in each fraction measured by BCA assay and concentration of DNA in culture 
broth measured by DPA assay. For fermentation 7, conditions were as fermentation 6 except 
that the IPTG concentration was increased to 0.2 mM. (d) Online fermentation parameters 
(Dissolved oxygen%, Temperature and pH). The arrow indicates the point of induction. (e) 
Optical density at 600 nm and concentration of Fab D1.3 measured by ELISA in each 
fraction. (f) Concentration of total protein in each fraction measured by BCA assay and 
concentration of DNA in culture broth measured by DPA assay. OS1, periplasmic extract; 
OS2, cytoplasmic extract; CB, culture broth. 
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Table 1. Summary of properties of periplasmic extracts from fermentations in this 
study. 
 
a. 100 x [Fab]/[Protein] for OS1 fraction. 
b. Time point for OS1 (periplasmic extract) data; relates to optimal harvest point as described in text. 
c. Determined by Bugbuster analysis followed by Western blotting and densitometric quantification; 
samples taken at end of fermentation. 
ND: Not determined 
Fermentation 
No. 
Fermentation conditions Optimal periplasmic (OS1) extract 
properties 
% Fab 
in 
soluble 
fractioncTemperature 
(°C) 
[IPTG] 
(μM) 
Induction 
point 
(OD600) 
 [Fab] 
(mg·L-
1) 
[Protein]
(mg·L-1) 
Fab 
purity 
(%)a 
Harvest 
point 
(h)b 
1 37 100 48 1.0 ND ND 12 25 
2 30 100 42 13.5 ND ND 18 40 
3 25 20 1 8.7 1050 0.8 22.5 94  
4 25 20 20 3.1 900 0.3 25 74 
5 25 100 20 12.5 2020 0.6 28 64  
6 25 Æ 20 100 20 15.8 850 1.9 36.5 77 
7 25 Æ 20 200 20 20 1190 1.7 26 61 
